Hantavirus prediction markets track forecasts around potential outbreaks, laboratory research discoveries, and disease detection events. These markets aggregate the collective expectations of participants on whether lab leaks will be confirmed, outbreaks will occur, or cases will be identified in specific regions and timeframes. Hantavirus is a family of viruses spread primarily through contact with infected rodent droppings, urine, or saliva. While cases have been documented across the Americas and Asia, public health agencies worldwide monitor for unusual clustering or novel transmission patterns. Prediction markets on Hantavirus reflect uncertainty around three key scenarios: **Lab discoveries**: Whether research into Hantavirus origins or synthesis capabilities will yield confirmed findings by certain dates—including potential lab-related release events. **Outbreak emergence**: The probability of significant outbreaks or clusters exceeding baseline case rates in defined regions by target dates. **US case detection**: The likelihood of confirmed Hantavirus cases appearing in the US within specified timeframes. Market prices—ranging from 1¢ to 99¢ per share—encode the collective estimate of each outcome's probability. A price of 65¢ implies a ~65% chance of the event occurring, while 20¢ suggests ~20%. **What moves these markets?** - Epidemiological reports and surveillance data from health agencies - Laboratory publications or announcements - Geographic and seasonal patterns in Hantavirus activity - Changes in testing capacity or case identification methods - Policy shifts affecting disease monitoring or research oversight Whether you're tracking public health trends, researching disease emergence risks, or analyzing how consensus forecasts evolve, Hantavirus prediction markets provide real-time signals of informed expectations. Prices update continuously as new information emerges.